Published in Immune Netw on April 23, 2015
Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses. Cell Mol Immunol (2016) 0.83
Nuclear factor kappa-B- and activator protein-1-mediated immunostimulatory activity of compound K in monocytes and macrophages. J Ginseng Res (2016) 0.75
Biologic basis for interleukin-1 in disease. Blood (1996) 16.04
Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol (2009) 14.33
Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science (1995) 11.38
Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med (2005) 9.47
The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol (2009) 7.80
The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity (2009) 6.37
Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol (2010) 6.05
Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med (2009) 5.77
Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature (1997) 5.35
Neonatal adaptive immunity comes of age. Nat Rev Immunol (2004) 5.31
Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity (1998) 4.70
IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev (2008) 4.68
The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity (2009) 4.51
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest (1991) 3.71
Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol (1997) 3.56
Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol (2010) 3.45
Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol (2007) 3.19
Interleukin-1 (IL-1) pathway. Sci Signal (2010) 2.58
Respiratory syncytial virus infection in mice. Infect Immun (1984) 2.14
TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS One (2012) 1.48
Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma. Eur J Immunol (2002) 1.38
Inflammasomes as mediators of immunity against influenza virus. Trends Immunol (2010) 1.35
Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection. J Immunol (2011) 1.33
Caspase-1: the inflammasome and beyond. Innate Immun (2013) 1.22
The use of a neonatal mouse model to study respiratory syncytial virus infections. Expert Rev Anti Infect Ther (2010) 1.10
Dual role of respiratory syncytial virus glycoprotein fragment as a mucosal immunogen and chemotactic adjuvant. PLoS One (2012) 1.05
Differential roles of lung dendritic cell subsets against respiratory virus infection. Immune Netw (2014) 0.85
Innate immune recognition of respiratory syncytial virus infection. BMB Rep (2014) 0.82
Regulating caspase-1 during infection: roles of NLRs, AIM2, and ASC. Yale J Biol Med (2011) 0.80